Abstract
hsMAD2, the human homologue of mitotic arrest deficient 2 (MAD2), is a key component of the mitotic checkpoint system. Recently, mutations and decreased expression of mitotic checkpoint genes including hsMAD2 have been reported in cancer cell lines with defective mitotic checkpoint. However, the genetic alterations in the genomic hsMAD2 gene have not been determined in gastric cancers. Moreover, the biological implications of the overexpressed hsMAD2 in primary cancers are unknown. In this study, we analyzed 32 primary gastric cancers with polymerase chain reaction (PCR) amplification of all exons, including flanking intronic sequences, of the genomic hsMAD2 gene followed by direct DNA sequencing. We also measured the hsMAD2 protein levels in cancer and normal tissues by semi‐quantitative immunoblotting. No mutations were found in the coding sequences, although three single nucleotide polymorphisms (SNPs) were identified in the noncoding sequences in 13 of 32 patients. These SNPs were not associated with either hsMAD2 expression or disease progression. The semi‐quantitative western blot analysis showed hsMAD2 was significantly overexpressed in gastric cancer tissues compared with corresponding normal tissues (P<0.001). The calculated ratio of the hsMAD2 protein in cancer tissue (C) to that in corresponding normal tissue (N) (C/N ratio) was significantly higher in patients with well differentiated adenocarcinoma (P=0.0274) or with synchronous liver metastasis (P=0.0025). A C/N ratio greater than 3 was observed more frequently in patients with synchronous liver metastasis. Therefore, C/N ratio >3 may be clinically important as a predictive indicator for metachronous liver metastasis of gastric cancers.
Keywords: hsMAD2, Human gastric cancer, Single nucleotide polymorphism, Liver metastasis, Predictive marker
Full Text
The Full Text of this article is available as a PDF (1,003.8 KB).
References
- 1.Li , R. and Murray , A. W.Feedback control of mitosis in budding yeast . Cell , 66 , 519 – 531 ( 1991. ). [DOI] [PubMed] [Google Scholar]
- 2.Orr‐Weaver , T. L. and Weinberg , R. A.A checkpoint on the road to cancer . Nature , 392 , 223 – 224 ( 1998. ). [DOI] [PubMed] [Google Scholar]
- 3.Pihan , G. A. and Doxsey , S. J.The mitotic machinery as a source of genetic instability in cancer . Semin. Cancer Biol. , 9 , 289 – 302 ( 1999. ). [DOI] [PubMed] [Google Scholar]
- 4.Cahill , D. P. , Lengauer , C. , Yu , J. , Riggins , G. J. , Willson , J. K. V. , Markowitz , S. D. , Kinzler , K. W. and Vogelstein , B.Mutations of mitotic checkpoint genes in human cancers . Nature , 392 , 300 – 303 ( 1998. ). [DOI] [PubMed] [Google Scholar]
- 5.Li , Y. and Benezra , R.Identification of a human mitotic checkpoint gene: hsMAD2 . Science , 274 , 246 – 248 ( 1996. ). [DOI] [PubMed] [Google Scholar]
- 6.Chen , R. H. , Waters , J. C. , Salmon , E. D. and Murray , A. W.Association of spindle assembly checkpoint component XMAD2 with unattached kinetochores . Science , 274 , 242 – 246 ( 1996. ). [DOI] [PubMed] [Google Scholar]
- 7.Pennisi , E.Cell division gatekeepers identified . Science , 279 , 477 – 478 ( 1998. ). [DOI] [PubMed] [Google Scholar]
- 8.Duesberg , P.Are centrosomes or aneuploidy the key to cancer ? Science , 284 , 2091 – 2092 ( 1999. ). [DOI] [PubMed] [Google Scholar]
- 9.Hagmann , M.Checkpoint gene linked to human cancer . Science , 286 , 2433 – 2434 ( 1999. ). [DOI] [PubMed] [Google Scholar]
- 10.Imai , Y. , Shiratori , Y. , Kato , N. , Inoue , T. and Omata , M.Mutationalinactivationof mitoticcheckpointgenes, hsMAD2 and hBUB1, is rare in sporadic digestive tract cancers . Jpn. J. Cancer Res. , 90 , 837 – 840 ( 1999. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Takahashi , T. , Haruki , N. , Nomoto , S. , Masuda , A. , Saji , S. , Osada , H. and Takahashi , T.Identification of frequent impairment of the mitotic checkpoint and molecular analysis of the mitotic checkpoint genes, hsMAD2 and p55CDC, in human lung cancers . Oncogene , 18 , 4295 – 4300 ( 1999. ). [DOI] [PubMed] [Google Scholar]
- 12.Cahill , D. P. , Costa , L. T. D. , Carson‐Walter , E. B. , Kinzler , K. W. , Vogelstein , B. and Lengauer , C.Characterization of MAD2B and other mitotic spindle checkpoint genes . Genomics , 58 , 181 – 187 ( 1999. ). [DOI] [PubMed] [Google Scholar]
- 13.Uchino , S. , Tsuda , H. , Noguchi , M. , Yokota , J. , Terada , M. , Saito , T. , Kobayashi , M. , Sugimura , T. and Hirohashi , S.Frequent loss of heterozygosity at the DCC locus in gastric cancer . Cancer Res. , 52 , 3099 – 3102 ( 1992. ). [PubMed] [Google Scholar]
- 14.Chen , R. H. , Brady , D. M. , Smith , D. , Murray , A. W. and Hardwick , K. G.The spindle checkpoint of budding yeast depends on a tight complex between the Mad 1 and Mad 2 proteins . Mol. Biol. Cell , 10 , 2607 – 2618 ( 1999. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Poelzl , G. , Kasai , Y. , Mochizuki , N. , Shaul , P. W. , Brown , M. and Mendelsohn , M. E.Specific association of estrogen receptor beta with the cell cycle spindle assembly checkpoint protein, MAD 2 . Proc. Natl. Acad. Sci.USA , 97 , 2836 – 2839 ( 2000. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.O'Neill , T. J. , Zhu , Y. and Gustafson , T. A.Interaction of MAD 2 with the carboxyl terminus of the insulin receptor but not with the IGFTR. Evidence for release from the insulin receptor after activation . J. Biol. Chem. , 272 , 10035 – 10040 ( 1997. ). [DOI] [PubMed] [Google Scholar]
- 17.Gliozzo , B. , Sung , C. K. , Scalia , P. , Papa , V. , Frasca , R , Sciacca , L. , Giorgino , F. , Milazzo , G. , Goldfine , I. D. , Vigneri , R. and Pezzino , V.Insulin‐stimulated cell growth in insulin receptor substrate‐1‐deficient ZR‐75‐1cells is mediatedby aphosphatidylinositol‐3‐kinase‐independent pathway . J. Cell. Biochem. , 70 , 268 – 280 ( 1998. ). [DOI] [PubMed] [Google Scholar]